Objectives: Anemia is a frequent disorder in patients with end stage renal disease.
Erythropoietin is advised in these patients; however, this therapy is not effective in patients …

Background The diagnosis of iron deficiency using the current commonly used tests is
usually difficult in hemodialysis patients. Soluble transferrin receptor (sTfR) has caught the …

Materials and Methods: In a cross-sectional study, 53 hemodialysis patients with a mean
age of 56±18.7 years and 30 persons with iron deficiency and normal renal function with a …

Methods This was a cross-sectional study that included 60 anemic patients with kidney
failure on regular HD for a minimum of 3 months. Patients were in the maintenance phase of …

Anemia in patients with chronic renal failure is multifactorial with an absolute or functional
iron deficiency present in 60–80% of patients. In this study, 102 patients of stage 5 chronic …

Dear Sir, In hemodialysis patients iron deficiency frequently occurs due to recombinant
human erythropoietin (r-HuEPO) treatment [1]. However, the diagnosis of iron deficiency is …

An adequate iron management is important in the treatment of anemia and in hemodialysis
(HD) patients. Serum ferritin and transferrin saturation (TS) may be influenced by the …

Background Serum transferrin receptor (sTfR) concentration has been recognized as a
reliable laboratory indicator of iron deficiency in recent years. But its response to iron …

Background. The aim of this study was to identify the factors determining the circulating
soluble transferrin receptor (sTfR) concentrations in haemodialysis (HD) patients on …

Summary Introduction. Transferrin (Tf) donates iron into cells through its interactions with a
membrane transferrin receptor (TfR) the quantity of which is proportional to the functional …